COVID-19 vaccines mix-and-match: The concept, the efficacy and the doubtsCOVID-19 백신 혼합 및 혼합: 개념, 효능 및 의심Review Published on 2022-04-012022-09-11 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 변종, [키워드] Administered Adverse reaction Adverse reactions cellular COVID-19 COVID-19 pandemic COVID-19 vaccine doses effective vaccine Effective vaccines Effectiveness Efficacy help heterologous vaccine humoral immune response immune responses IMPROVE in some match mix-and-match overcome reduced Region regions SARS-CoV-2 significantly solution the vaccine vaccination Vaccine vaccine dose vaccine doses variants of concern [DOI] 10.1002/jmv.27463 PMC 바로가기 [Article Type] Review
Relation of fever intensity and antipyretic use with specific antibody response after two doses of the BNT162b2 mRNA vaccineBNT162b2 mRNA 백신 2회 접종 후 발열 강도 및 해열제 사용과 특이 항체 반응의 관계Article Published on 2022-03-182022-09-12 Journal: Vaccine [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] acquisition Adverse reaction Adverse reactions age Analysis analyzed antibody Antibody Response Antipyretic antipyretics association BNT162b2 mRNA vaccine body temperature collected correlated COVID-19 COVID-19 vaccine degree dose female Fever FIVE healthcare worker highest hospital IgG IgG titer IgG titers intensity interfere investigated medication mitigate Multivariate analysis of BNT162b2 participant positive correlation questionnaire reactogenicity reactogenicity event relation reported responses SARS-CoV-2 second dose serum sample Sex significantly spike-specific IgG the SARS-CoV-2 Vaccine was measured [DOI] 10.1016/j.vaccine.2022.02.025 PMC 바로가기 [Article Type] Article
Various painful oral adverse reactions following COVID-19 vaccination: a case seriesCase Report Published on 2022-03-082022-10-28 Journal: BMC Oral Health [Category] COVID-19, Fulltext, MERS, SARS, [키워드] Adverse adverse effect Adverse reaction analyzed Case report case sery Characteristics clinical Complication COVID-19 COVID-19 vaccination COVID-19 vaccine event generally mild Gingiva incidence increasingly lower second molar medication mucosa nine oral oral mucosa Orofacial pain Pain palatal Patient reported reported symptoms SARS-CoV-2 vaccination swelling Symptom tongue Treatment ulceration vaccination [DOI] 10.1186/s12903-022-02100-w PMC 바로가기 [Article Type] Case Report
Clinical Features of Patients Presenting to the Emergency Department With Cardiovascular Adverse Reactions After COVID-19 mRNA VaccinationObservational Study Published on 2022-03-072022-10-04 Journal: Journal of Korean medical science [Category] SARS, 임상, [키워드] Admission Adverse adverse effects adverse event Adverse reaction cardiovascular Cardiovascular Symptoms Chest chief complaint clinical Clinical data clinical feature collected conducted coronavirus disease COVID-19 COVID-19 mRNA Vaccination Department diagnosed Diagnosis differential diagnosis discharged disease Dyspnea Emergency emergency department female females Final highest hospital implementation investigated male males medical records Mild MOST mRNA nonspecific palpitation Patient patients Physicians postvaccination progression reaction Reactions retrospective second dose selected Surveillance vaccination Vaccine vaccine dose [DOI] 10.3346/jkms.2022.37.e73 PMC 바로가기 [Article Type] Observational Study
COVID-19 Vaccination within the Context of Reactogenicity and Immunogenicity of ChAdOx1 Vaccine Administered to Teachers in Poland폴란드 교사에게 투여된 ChAdOx1 백신의 반응성 및 면역원성의 맥락에서 COVID-19 백신 접종Article Published on 2022-03-062022-09-10 Journal: International Journal of Environmental Research an [Category] MERS, SARS, 진단, 치료기술, [키워드] adverse effects Adverse reaction Adverse reactions age All participant All participants anti-RBD Anti-RBD IgG Antibody Response ChAdOx1 ChAdOx1 vaccine ChAdOx1-S chills Context COVID-19 demonstrated detectable determinants dose dosing interval Efficacy ENhance female first dose headache immunogenicity immunologic response immunologic responses individual Infection interval malaise male mRNA multivariate logistic regression offered Older participant Participants Poland predictor RBD reactogenicity Receptor-binding domain Region reported required SARS-CoV-2 SARS-COV-2 infection Serological testing Side effect Side effects Support teacher teachers the mean the median the receptor-binding domain Tolerability uninfected Vaccine were measured [DOI] 10.3390/ijerph19053111 PMC 바로가기 [Article Type] Article
Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial중국 성인을 대상으로 한 SARS-CoV-2 ARCoV mRNA 백신의 안전성 및 면역원성: 무작위 배정, 이중 맹검, 위약 대조, 1상 시험Clinical Trial Published on 2022-03-012022-09-11 Journal: The Lancet. Microbe [Category] MERS, SARS, 임상, 진단, 치료기술, [키워드] abnormal change abnormal changes Academy administration adverse event adverse events Adverse reaction Adverse reactions All participant All participants analyses Analysis Anti-RBD IgG anti-SARS-CoV-2 Antibody titre assigned baseline block Block randomisation caused cellular immune responses China Chinese clinical testing conducted convalescent patient Convalescent patients COVID-19 pandemic development domain dose dose-escalation doses double-blind effective vaccine Effective vaccines eligible participant ELISA ELISPOT ENCODE enrolled enzyme enzyme-linked immunospot expected exploratory Fever first vaccination FIVE foundation grade 3 group groups highest hospital humoral humoral immune responses Humoral response humoral responses IFN-γ IL-2 immune immune response immune responses immunogenicity incidence individual Intramuscular injection investigators Laboratory laboratory analyses Laboratory test Laboratory tests live SARS-CoV-2 lowest majority Medical Science Medical Sciences Mild moderate mRNA vaccine natural neutralisation assays Neutralising Antibodies neutralising antibody observation outcome participant Participants peaked Phase 1 phase 1 trial Placebo placebo group placebo-controlled Primary outcome pseudovirus randomised Randomly RBD RBD IgG RBD-specific IgG receive Registered reported research and development resolved Safe Safety safety analyses safety profile SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2-specific T-cell response SARS-CoV-2-specific T-cell responses Science screened second dose second vaccination secondary outcome Serious Adverse Event Serious Adverse Events Seven significantly Specific Specific T-cell response Spike protein Support systemic adverse event T-cell Response T-cell responses the placebo group the SARS-CoV-2 titre titres Tolerability treatment allocation Trial vaccination Vaccine vaccine dose vaccine doses were assessed were given with COVID-19 Zhejiang [DOI] 10.1016/S2666-5247(21)00280-9 PMC 바로가기 [Article Type] Clinical Trial
Adverse reactions and production of neutralizing anti-SARS-CoV-2 antibodies after ChAdOx1 COVID-19 vaccination: A cross-sectional study in a single centerChAdOx1 COVID-19 백신 접종 후 중화 항 SARS-CoV-2 항체의 부작용 및 생성: 단일 센터의 단면 연구Article Published on 2022-03-012022-09-12 Journal: Journal of infection and public health [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] Adverse Adverse reaction anti-SARS-CoV-2 antibody blood sample ChAdOx1 ChAdOx1 vaccine collected coronavirus COVID-19 COVID-19 vaccine cPass™ cross-sectional dose ELISA enrolled event first dose HCW median NAb NAbs Neutralizing Neutralizing antibodies neutralizing antibody response SARS-CoV-2 SARS-CoV-2 NAb second dose significantly higher single center systemic adverse event USA vaccination Vaccine [DOI] 10.1016/j.jiph.2022.02.005 PMC 바로가기 [Article Type] Article
Impact of age, sex and medical history on adverse reactions to the first and second dose of BNT162b2 mRNA COVID-19 vaccine in Japan: a cross-sectional studyResearch Published on 2022-02-232022-10-28 Journal: BMC Infectious Diseases [Category] COVID-19, COVID19(2023년), Fulltext, MERS, SARS, [키워드] acute respiratory syndrome adverse effect Adverse reaction Adverse reactions age analyzed BNT162b2 caused collected coronavirus coronavirus disease correlation COVID-19 COVID-19 vaccine cross-sectional dental dose fatigue female females first vaccination headache Impact incidence injection Japan Logistic regression analysis male mRNA of BNT162b2 Older profile promoted Questionnaires recipients regression analysis Result SARS-CoV-2 second dose second vaccination severity Sex significant negative correlation significantly higher subject university vaccination younger people [DOI] 10.1186/s12879-022-07175-y PMC 바로가기 [Article Type] Research
Effectiveness of neutralizing antibody cocktail in hemodialysis patients: a case series of 20 patients treated with or without REGN-COV2혈액투석 환자에서 중화항체 칵테일의 효과: REGN-COV2 유무에 관계없이 20명의 환자를 대상으로 한 일련의 사례Original Article Published on 2022-02-182022-09-12 Journal: Clinical and experimental nephrology [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] Admission Adverse reaction antibodies antibody cocktail approval average can be used case sery COVID-19 death dialysis disease duration of hospitalization effective end-stage kidney disease Fever FIVE global pandemic Hemodialysis high risk hospital Infection intravenous Japan Kidney disease less medication Mild moderate disease neutralizing antibody Patient patients patients treated patients with COVID-19 patients with SARS-CoV-2 Pneumonia progressed REG-COV2 (a neutralizing antibody cocktail) REGN-CoV2 Safe severe disease severity shown treated Treatment [DOI] 10.1007/s10157-021-02151-3 PMC 바로가기 [Article Type] Original Article
Flavonoids for Treating Viral Acute Respiratory Tract Infections: A Systematic Review and Meta-Analysis of 30 Randomized Controlled Trials바이러스성 급성 호흡기 감염 치료를 위한 플라보노이드: 30건의 무작위 대조 시험에 대한 체계적인 검토 및 메타 분석Meta-Analysis Published on 2022-02-162022-09-11 Journal: Frontiers in Public Health [Category] COVID19(2023년), SARS, 임상, [키워드] achievement acute bronchitis acute respiratory tract infection adverse event adverse events Adverse reaction Adverse reactions alleviation alleviation of symptoms analyzed bronchial pneumonia bronchitis BSS changes in clearance common cold complementary and alternative medicine control group Controlled Controlled trial controlled trials COVID-19 duration of illness Efficacy analyses efficacy analysis Efficacy and safety eligible flavonoid flavonoids Hospitalization ICU Identifier incidence infections Influenza intensity limitations mechanical ventilation meta-analyses Meta-analysis Mortality not differ oxygen Patient patients hospitalized performed positive RCT RCTs respiratory respiratory tract infection Respiratory tract infections Result review rhinosinusitis RT-PCR Safe Safety severity sinusitis subject substantial risk suggested Symptom Symptoms systematic review TNF-α tonsillitis tonsillopharyngitis tract treating trials TSS Tumor tumor necrosis tumor necrosis factor tumor necrosis factor-α upper respiratory tract upper respiratory tract infections Viral [DOI] 10.3389/fpubh.2022.814669 PMC 바로가기 [Article Type] Meta-Analysis